Referral patterns to an osteoporosis clinic for dermatology patients undergoing prolonged corticosteroid therapy

To the Editor: Glucocorticoids are frequently used in dermatology. Glucocorticoid-induced osteoporosis (GIOP) is a well-recognized side effect with substantial morbidity. GIOP prevention measures are essential for bone health. Studies have shown dermatologists are underutilizers of bisphosphonates, first-line agents for osteoporosis prevention.1 A high-risk osteoporosis clinic (HIROC) developed by the rheumatology department was established at the Geisinger Medical Center. This retrospective cohort study reviewed dermatology patients taking oral glucocorticoids for more than 30 consecutive days to determine referral patterns to the HIROC, completion rate of referrals, and follow-up interventions.